Cargando…
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
The cell cycle and its regulators are validated targets for cancer drugs. Reagents that target cells in a specific cell cycle phase (e.g., antimitotics or DNA synthesis inhibitors/replication stress inducers) have demonstrated success as broad‐spectrum anticancer drugs. Cyclin‐dependent kinases (CDK...
Autores principales: | Rao, Chinthalapally V., Asch, Adam S., Carr, Daniel J. J., Yamada, Hiroshi Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059149/ https://www.ncbi.nlm.nih.gov/pubmed/31981470 http://dx.doi.org/10.1111/acel.13109 |
Ejemplares similares
-
GSK3‐ARC/Arg3.1 and GSK3‐Wnt signaling axes trigger amyloid‐β accumulation and neuroinflammation in middle‐aged Shugoshin 1 mice
por: Rao, Chinthalapally V., et al.
Publicado: (2020) -
Spontaneous development of Alzheimer's disease‐associated brain pathology in a Shugoshin‐1 mouse cohesinopathy model
por: Rao, Chinthalapally V., et al.
Publicado: (2018) -
Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on Copy Number Alterations
por: Rao, Chinthalapally V., et al.
Publicado: (2022) -
How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
por: Rao, Chinthalapally V., et al.
Publicado: (2021) -
Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2021)